The US Food and Drug Administration (FDA) authorized for marketing the Affymetrix CytoScan Dx Assay, which can detect chromosomal variations that may be responsible for a child’s developmental delay ...
An eight-year retrospective study demonstrated that chromosomal microarray analysis delivered an incremental diagnostic yield ...
The nation’s pediatricians are getting new guidelines for how to go about evaluating children who present with global developmental delay or intellectual disability. Doctors should use genetic testing ...
A ten-year study of 849 pregnancy loss samples demonstrates that chromosomal microarray testing detects genetic abnormalities in over sixty-two percent of cases, with risk rising steeply alongside ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results